Search results :

Albendazole

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: P02CA03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Liver function test abnormal 1% - 15.6% x x
Headache 1.3% - 11% x x
Nausea 3.7% - 6.2% x x
Vomiting 3.7% - 6.2% x x
Abdominal pain 0% - 6% x x
Alopecia reversible 1% - 1.6% x x
Dizziness 1% - 1.2% x x
Vertigo 1% - 1.2% x x
Intracranial pressure increased 0% - 1.5% x x
Leukopenia 0.7% x x
Body temperature increased 0% - 1% x x
Aplastic anaemia postmarketing x x
Erythema multiforme postmarketing x x
Rash postmarketing x x
Hepatitis postmarketing x x
Hypersensitivity postmarketing x x
Immune system disorder postmarketing x x
Renal failure acute postmarketing x x
Neutropenia postmarketing x x
Stevens-Johnson syndrome postmarketing x x
Urinary tract disorder postmarketing x x
Urticaria postmarketing x x
Acute hepatic failure postmarketing x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x
Hepatobiliary disease postmarketing x x
Blood and lymphatic system disorders postmarketing x x
Agranulocytosis x x
Pancytopenia x x
Thrombocytopenia x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ALBENDAZOLE

Side effects:29
Source:FDA Structured Product Label

ALBENDAZOLE / ALBENZA

Side effects:29
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label